Nitrous Oxide and Carbon Dioxide: Their Similar and Contrasting

Total Page:16

File Type:pdf, Size:1020Kb

Nitrous Oxide and Carbon Dioxide: Their Similar and Contrasting 104 South African Journal of Science 103, March/April 2007 Research in Action between CO2 and N2O in the atmosphere Nitrous oxide and carbon dioxide: and ocean. their similar and contrasting Nitrous oxide, like carbon dioxide, is produced endogenously biological effects Nitrous oxide is a metabolic product of certain bacteria, some of which are † M.A. Gillman*‡ and F.J. Lichtigfeld* commensals in the gut of animals includ- ing man.10 In recent years, moreover, evidence has appeared indicating that N2O may be produced in mammalian he similar and contrasting biological 4,7 the CO2 involved in photorespiration. cells as part of their metabolism. When properties of CO2 and N2O appear to Plants acquire their nitrogen either directly we discovered that N2O could be involved Treflect fundamental biological processes from the soil or through internal recycling in neurotransmission in humans,11–13 we in both very simple and the most complex organisms. of nitrate and ammonium. The amount of did not realize that we had stumbled on a ammonium recyling in C3 plants is signifi- new biological principle. The generality of our finding was confirmed when nitric Introduction cantly higher than in C4 plants as a result A recent article in this journal1 discussed of photorespiration. As the rate of ammo- oxide (NO), another endogenously pro- duced gas, was also discovered to have a the similarities and differences between nia production in C3 plants can be 20 times the rate of primary nitrate assimilation, role in neurotransmission.14,15 nitrous oxide (N2O) and carbon dioxide the plant cannot afford to lose this ammo- The evidence that N2O is produced (CO2) from a physico-chemical perspective. 4,7 Here we consider the apparent similarities nia as a volatile gas but must have an endogenously seems to confirm the and differences between these two gases effective mechanism for its re-assimi- possibility that it is not only the first gas to in a biological context. lation. Three enzymes (glutamine synthe- have been shown to have a role in neuro- tase, glutamate synthase and glutamate transmission but that it is formed by the It is well known that biologically active 16,17 chemical agents can act directly with dehydrogenase) have been identified in catabolism of NO. This once again highlights the similarities of N O and receptors in the brain to produce physio- transforming ammonia into amino acids 2 2 CO , which both appear to be endoge- logical and pharmacological effects. but there is debate as to the role of the 2 These receptors have unique and specific various oxidized nitrogen intermediates nously produced as metabolic products in physico-chemical structures and proper- which are formed.3 It is possible that bacterial and mammalian cells. These ties. Chemical substances that attach to one of these oxides is NO, which may be gases are therefore involved in the physi- ology of cells from the simplest to the these receptors do so by characteristic reduced to N2O as has been shown in physico-chemical mechanisms, which mammalian cells4 and bacteria.5 In sup- most complex life forms. This is perhaps not surprising, given that N O and CO then trigger a cascade of events through port of this idea, plants have been shown 2 2 are linked through the nitrogen and the interaction of the particular agent to emit endogenously produced N2O 2 carbon cycles (see above), which are with the specific receptor. It is therefore during nitrate assimilation.6 not surprising that the structural similari- crucial to living organisms. Nitrous oxide does not substitute for O2 ties of the N2O and CO2 molecules translate in either the cytochrome c oxidase or Actions on the nervous system into similar biological actions. On the carbon monoxide (CO) diogenase reac- In higher animals, N O and CO have other hand, such structural and other tions that produce, respectively, water 2 2 related actions on the nervous system. differences as they have may account for and CO and which are both catalysed by 2 Both gases in high concentrations cause their dissimilar biological effects. cytochrome c oxidase.7 Rather, it acts by depression of the central nervous system, reducing the rate of electron transfer from Nitrogen and carbon cycles leading eventually to coma, respiratory cytochrome c to the O reaction site.7 It is Photorespiration involves the light- 2 depression and finally death.18–20 Despite therefore possible that N O interacts with dependent evolution of CO and uptake 2 these apparent similarities, however, 2 CO in the plant cell by reducing the flow of oxygen in green leaves. During the 2 there are differences in their biological of electrons to both CO and O reaction 19,20 1950s and 1960s, the synthesis of glycolate 2 2 effects. sites. The latter postulate is supported by by leaves in high O concentrations or low 2 the finding that N O inhibits the use of O CO settings was demonstrated and the 2 2 Respiration 2 by plant tissue.8 enzymic pathways involved were eluci- The effects of N2O on respiratory drive 3 The link between N Oand CO through dated. Ribulose bisphosphate carboxy- 2 2 are relatively small, with slight depression lase/oxygenase (rubisco, RuBP) is the the carbon and nitrogen cycles is also seen of the stimulatory response in humans to in the composition of the atmosphere and 19 primary enzyme involved, with both CO2 CO2 when 50% N2O in oxygen is breathed. oceans during glacial cycles.9 The end of a and O2 competing for its active site, the The response to hypoxia is also reduced glacial cycle is marked by the outgassing position on the enzyme to which the sub- when 50% N2O is breathed. Since N2Oat strate binds. There is a well-established of N2O, a greenhouse gas, from sea water. non-anaesthetic concentrations (such as link between photorespiration and the This is described by a nonlinear model 50%) is an multipotent opioid agonist,21–23 nitrogen cycle in plants. During the which takes into account the effect of its depressant effect on respiration could decarboxylation of glycine, ammonia is variations in the ocean’s content of fixed be opioid mediated. Nevertheless, it is produced in stoichiometric amounts with nitrogen following enhanced denitrifi- much less marked than some other opioids cation.9 Outgassing leads to greater levels and particularly those that are selective *South African Brain Research Institute, 6 Campbell St, Waverley, Johannesburg 2090, South Africa. of atmospheric CO2 during interglacial mu-opioid agonists, such as morphine. † 9 Deceased. periods, showing a direct relationship Competitive opioid antagonists such as ‡Author for correspondence. E-mail: [email protected] Research in Action South African Journal of Science 103, March/April 2007 105 nalorphine and naloxone can reverse consequences are almost certainly recep- Other workers have shown that both 24,25 16,17,21,22,28,31–33 these effects on respiration. Such antag- tor mediated and could also be N2O and hyperventilation have similar onistic outcomes on respiratory depression responsible for its actions on the respira- inhibitory effects on lamina V of the spinal are extremely rapid as would be expected tory centres. cord, where there is convergence of visceral because they are mediated by direct effects and high threshold cutaneous pain.40 on opioid receptors. Moreover, endoge- Sympathetic activity These laminae are rich in opioid termi- nous and exogenous opioids, including Sympathetic activity, which prepares nals.41 N2O, inhibit the responses of the brain- the body for the fright/flight response, is These findings seem to indicate that stem respiratory centre to increased CO increased by both N O34,35 and CO .20 2 2 2 CO2 , like N2O, acts directly on mu-opioid 19 blood levels. Thus, the control of respira- Nitrous oxide seems to act directly at receptors, especially in their effects on tory function ‘may be directly related to opioid receptors as well as via the alpha2- pain perception and possibly also in their 36 competition for opioid receptor sites by adrenergic system. Carbon dioxide actions on respiration as suggested previ- these various gases as well as endogenous potently activates the central adrenergic ously (see above) on the basis of radio- 22 20 opioid agents.’ It is therefore significant system and there is some preliminary receptor assays.22 that the depressant effect of morphine on evidence that it acts directly on mu-opioid 28 respiration can be as rapidly reversed by receptors, further underlining the simi- Other pharmacological actions of CO 26 2 inhalation of 5% CO2 in oxygen, indicat- larity between the biological actions of and N2O on the central nervous system ing the possibility that this effect is also these two gases. The descending adre- Pharmacological, rather than physio- receptor mediated. nergic and nor-adrenergic cell groups logical, concentrations of CO2 produce 42,43 That this influence of CO2 is likely to form most of the lateral medullary stress reactions such as anxiety and fear. involve receptors is supported by the fact reticular formation and are linked to This outcome is probably mediated by that stimulation of ventilation in man various vital centres in the medulla stimulation of the sympathetic system20 begins within seconds of inhaling low oblongata of the brainstem, which includes and blockade of opioid receptors.26 In 37 concentrations of the gas, with a maximum the respiratory centres. contrast, although also heightening sym- response occurring within less than 5 Apart from the influence of these gases 19,20 20 pathetic stimulation, non-anaesthetic minutes. These stimulatory consequences on the adrenergic system, they also have doses of N O have anti-stress effects44–47 of CO inhalation disappear rapidly after 2 2 local effects.
Recommended publications
  • Pharmacology
    Pharmacology New for 2020-2021 Competitor orientation deleted from ILC. Event Summary Pharmacology provides HOSA members with the opportunity to gain knowledge and skills regarding the area of healthcare concerned with uses, effects, and modes of actions of drugs. This competitive event consists of a written test with a tie-breaker essay question. This event aims to inspire members to learn about how drugs work in the body, proper administration, and adaptations for different patients and conditions. Dress Code Competitors must be in official HOSA uniform or proper business attire. Bonus points will be awarded for proper dress. General Rules 1. Competitors in this event must be active members of HOSA-Future Health Professionals, in good standing. 2. Secondary and Postsecondary/Collegiate divisions are eligible to compete in this event. 3. Competitors must be familiar with and adhere to the “General Rules and Regulations of the HOSA Competitive Events Program (GRR)." 4. All competitors shall report to the site of the event at the time designated for each round of competition. At ILC, competitor’s photo ID must be presented prior to ALL competition rounds. Official References • Fulcher, Soto and Fulcher. Pharmacology: Principles and Applications. Elsevier, Latest edition. • Ford, Susan and Sally Roach. Roach’s Introductory Clinical Pharmacology. Wolters Kluwer, Latest edition. Written Test 5. Test Instructions: The written test will consist of 100 multiple choice items in a maximum of 90 minutes. 6. Time Remaining Announcements: There will be a verbal announcement when there are 60 minutes, 30 minutes, 15 minutes, 5 minutes, and 1 minute remaining to complete the test.
    [Show full text]
  • Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development
    Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development Gerlie Gieser, Ph.D. Office of Clinical Pharmacology, Div. IV Objectives • Outline the Phase 1 studies conducted to characterize the Clinical Pharmacology of a drug; describe important design elements of and the information gained from these studies. • List the Clinical Pharmacology characteristics of an Ideal Drug • Describe how the Clinical Pharmacology information from Phase 1 can help design Phase 2/3 trials • Discuss the timing of Clinical Pharmacology studies during drug development, and provide examples of how the information generated could impact the overall clinical development plan and product labeling. Phase 1 of Drug Development CLINICAL DEVELOPMENT RESEARCH PRE POST AND CLINICAL APPROVAL 1 DISCOVERY DEVELOPMENT 2 3 PHASE e e e s s s a a a h h h P P P Clinical Pharmacology Studies Initial IND (first in human) NDA/BLA SUBMISSION Phase 1 – studies designed mainly to investigate the safety/tolerability (if possible, identify MTD), pharmacokinetics and pharmacodynamics of an investigational drug in humans Clinical Pharmacology • Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of the drug in humans – PK: what the body does to the drug (Absorption, Distribution, Metabolism, Excretion) – PD: what the drug does to the body • PK and PD profiles of the drug are influenced by physicochemical properties of the drug, product/formulation, administration route, patient’s intrinsic and extrinsic factors (e.g., organ dysfunction, diseases, concomitant medications,
    [Show full text]
  • Understanding Pigments: the Third Step to Higher Quality And
    Understanding Pigments: The Third Mark Harber October, 2000 Step to Higher Quality and Consistency Putting great color in your product is part of the pigments. However, they are less opaque and systems approach for resolving issues of sub- would have to be used at higher loading levels to standard properties and appearance. achieve similar whiteness and opacity. This article on pigments is the third in a four-part Titanium Dioxide is used in the majority of the series about the interrelationship of the material products made by the cast polymer industry. Tita- components used in marble and solid surface nium Dioxide-based colors include most whites, manufacturing. These AOC-authored articles re- pastels, earth tones and off-whites such as bone, spond to the challenge that the cast polymer in- ivory, beige or biscuit. As noted in Table 1, non- dustries aspire to higher standards of quality and white synthetic oxides are combined with Titani- consistency. Because resolving cast polymer is- um Dioxide to create pastels and earth tones for sues requires a systems approach, other articles cultured marble and solid surface applications. in this series address resins, gel coats and pro- cessing. All articles begin with background infor- Phthalocyanine pigments, or "Phthalos," impart mation on the main subject matter, followed by deep colors such as the automotive "Hunter ten related issues and guidelines. Green" of a sport utility vehicle or the high strength Blue used in ballpoint pens. Because A BACKGROUND ON COLORANTS they are so deep when used by themselves, In their natural state, cast polymer resins meet a Phthalo Blue and Phthalo Green are normally variety of performance requirements but are lack- blended with other pigments, many times Titani- ing in the color that draws the customer to the um Dioxide.
    [Show full text]
  • I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St
    2014;22(1):13-18 TCP Translational and Clinical Pharmacology http://dx.doi.org/10.12793/tcp.2014.22.1.13 Clinical Pharmacology Review for Primary Health Care Providers: I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 137-701, Korea *Correspondence: S. Han; Tel: +82-2-2258-7326, Fax: +82-2-2258-7876, E-mail: [email protected] Received 31 May 2014 Primary health care providers play a critical role in maintaining public health, and the appropri- Accepted 31 May 2014 ate use of pharmaceutical products is one of the major parts of their practice. This series of articles, pISSN: 2289-0882 entitled ‘Clinical Pharmacology Review for Primary Health Care Providers,’ is intended to help pri- mary health care providers select more appropriate prescriptions for frequently used drugs based on up-to-date information. We expect that this effort will contribute to improvements in public health and diminish unnecessary drug use. Introduction tion on the H1 receptor.[8] THERAPEU Antihistamines include some of the most frequently prescribed drugs in the primary health care environment for the symp- Generations and Classes tomatic relief of allergic diseases, the common cold, urticaria, Many primary health care providers are well-informed about T and insomnia.[1-5] The importance of antihistamines has been the different ‘generations’ of antihistamines but not about the ICS TU emphasized as the prevalence of target diseases increases.[6,7] different ‘classes’ characterized according to chemical structure. However, the appropriate use, clinical effectiveness, and target [1] This discrepancy seems reasonable because ‘inter-generation’ T populations for prescription of antihistamines are still a matter differences are more prominent than ‘inter-class’ differences.
    [Show full text]
  • Guidance for Reviewers Pharmacology/Toxicology Review Format
    Guidance for Reviewers Pharmacology/Toxicology Review Format U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Pharmacology/Toxicology May 2001 Guidance for Reviewers Pharmacology/Toxicology Review Format Additional copies are available from: Drug Information Branch (HFD-210) Center for Drug Evaluation and Research (CDER) 5600 Fishers Lane, Rockville, MD 20857, (Tel) 301-827-4570 Internet at http://www.fda.gov/der/guidance/index.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Pharmacology/Toxicology May 2001 Guidance for Reviewers Table of Contents I. INTRODUCTION ....................................................................................................1 II. BACKGROUND.......................................................................................................1 III. DISCUSSION ...........................................................................................................1 A. IND REVIEW FORMAT ....................................................................................1 B. NDA REVIEW FORMAT...................................................................................1 IV. ATTACHMENTS .....................................................................................................1 A. IND REVIEW FORMAT ....................................................................................A-i B. NDA REVIEW FORMAT...................................................................................B-i
    [Show full text]
  • Department of Pharmacology (GRAD) 1
    Department of Pharmacology (GRAD) 1 faculty participate fully at all levels. The department has the highest DEPARTMENT OF level of NIH funding of all pharmacology departments and a great diversity of research areas is available to trainees. These areas PHARMACOLOGY (GRAD) include cell surface receptors, G proteins, protein kinases, and signal transduction mechanisms; neuropharmacology; nucleic acids, cancer, Contact Information and antimicrobial pharmacology; and experimental therapeutics. Cell and molecular approaches are particularly strong, but systems-level research Department of Pharmacology such as behavioral pharmacology and analysis of knock-in and knock-out Visit Program Website (http://www.med.unc.edu/pharm/) mice is also well-represented. Excellent physical facilities are available for all research areas. Henrik Dohlman, Chair Students completing the training program will have acquired basic The Department of Pharmacology offers a program of study that leads knowledge of pharmacology and related fields, in-depth knowledge in to the degree of doctor of philosophy in pharmacology. The curriculum is their dissertation research area, the ability to evaluate scientific literature, individualized in recognition of the diverse backgrounds and interests of mastery of a variety of laboratory procedures, skill in planning and students and the broad scope of the discipline of pharmacology. executing an important research project in pharmacology, and the ability The department offers a variety of research areas including to communicate results, analysis, and interpretation. These skills provide a sound basis for successful scientific careers in academia, government, 1. Receptors and signal transduction or industry. 2. Ion channels To apply to BBSP, students must use The Graduate School's online 3.
    [Show full text]
  • Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 11
    This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=13374 Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 11 ISBN Committee on Acute Exposure Guideline Levels; Committee on 978-0-309-25481-6 Toxicology; National Research Council 356 pages 6 x 9 PAPERBACK (2012) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 11 Committee on Acute Exposure Guideline Levels Committee on Toxicology Board on Environmental Studies and Toxicology Division on Earth and Life Studies Copyright © National Academy of Sciences. All rights reserved. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 11 THE NATIONAL ACADEMIES PRESS 500 FIFTH STREET, NW WASHINGTON, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Insti- tute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
    [Show full text]
  • Ocean Storage
    277 6 Ocean storage Coordinating Lead Authors Ken Caldeira (United States), Makoto Akai (Japan) Lead Authors Peter Brewer (United States), Baixin Chen (China), Peter Haugan (Norway), Toru Iwama (Japan), Paul Johnston (United Kingdom), Haroon Kheshgi (United States), Qingquan Li (China), Takashi Ohsumi (Japan), Hans Pörtner (Germany), Chris Sabine (United States), Yoshihisa Shirayama (Japan), Jolyon Thomson (United Kingdom) Contributing Authors Jim Barry (United States), Lara Hansen (United States) Review Editors Brad De Young (Canada), Fortunat Joos (Switzerland) 278 IPCC Special Report on Carbon dioxide Capture and Storage Contents EXECUTIVE SUMMARY 279 6.7 Environmental impacts, risks, and risk management 298 6.1 Introduction and background 279 6.7.1 Introduction to biological impacts and risk 298 6.1.1 Intentional storage of CO2 in the ocean 279 6.7.2 Physiological effects of CO2 301 6.1.2 Relevant background in physical and chemical 6.7.3 From physiological mechanisms to ecosystems 305 oceanography 281 6.7.4 Biological consequences for water column release scenarios 306 6.2 Approaches to release CO2 into the ocean 282 6.7.5 Biological consequences associated with CO2 6.2.1 Approaches to releasing CO2 that has been captured, lakes 307 compressed, and transported into the ocean 282 6.7.6 Contaminants in CO2 streams 307 6.2.2 CO2 storage by dissolution of carbonate minerals 290 6.7.7 Risk management 307 6.2.3 Other ocean storage approaches 291 6.7.8 Social aspects; public and stakeholder perception 307 6.3 Capacity and fractions retained
    [Show full text]
  • Bioinorganic Chemistry Content
    Bioinorganic Chemistry Content 1. What is bioinorganic chemistry? 2. Evolution of elements 3. Elements and molecules of life 4. Phylogeny 5. Metals in biochemistry 6. Ligands in biochemistry 7. Principals of coordination chemistry 8. Properties of bio molecules 9. Biochemistry of main group elements 10. Biochemistry of transition metals 11. Biochemistry of lanthanides and actinides 12. Modell complexes 13. Analytical methods in bioinorganic 14. Applications areas of bioinorganic chemistry "Simplicity is the ultimate sophistication" Leonardo Da Vinci Bioinorganic Chemistry Slide 1 Prof. Dr. Thomas Jüstel Literature • C. Elschenbroich, A. Salzer, Organometallchemie, 2. Auflage, Teubner, 1988 • S.J. Lippard, J.N. Berg, Bioinorganic Chemistry, Spektrum Akademischer Verlag, 1995 • J.E. Huheey, E. Keiter, R. Keiter, Anorganische Chemie – Prinzipien von Struktur und Reaktivität, 3. Auflage, Walter de Gruyter, 2003 • W. Kaim, B. Schwederski: Bioinorganic Chemistry, 4. Auflage, Vieweg-Teubner, 2005 • H. Rauchfuß, Chemische Evolution und der Ursprung des Lebens, Springer, 2005 • A.F. Hollemann, N. Wiberg, Lehrbuch der Anorganischen Chemie, 102. Auflage, de Gruyter, 2007 • I. Bertini, H.B. Gray, E.I. Stiefel, J.S. Valentine, Biological Chemistry, University Science Books, 2007 • N. Metzler-Nolte, U. Schatzschneier, Bioinorganic Chemistry: A Practical Course, Walter de Gruyter, 2009 • W. Ternes, Biochemie der Elemente, Springer, 2013 • D. Rabinovich, Bioinorganic Chemistry, Walter de Gruyter, 2020 Bioinorganic Chemistry Slide 2 Prof. Dr. Thomas Jüstel 1. What is Bioinorganic Chemistry? A Highly Interdisciplinary Science at the Verge of Biology, Chemistry, Physics, and Medicine Biochemistry Inorganic Chemistry (Micro)- Physics & Biology Spectroscopy Bioinorganic Chemistry Pharmacy & Medicine & Toxicology Physiology Diagnostics Bioinorganic Chemistry Slide 3 Prof. Dr. Thomas Jüstel 2. Evolution of the Elements Most Abundant Elements in the Universe According to Atomic Fraction Are: 1.
    [Show full text]
  • Titanium Dioxide Production Final Rule: Mandatory Reporting of Greenhouse Gases
    Titanium Dioxide Production Final Rule: Mandatory Reporting of Greenhouse Gases Under the Mandatory Reporting of Greenhouse Gases (GHGs) rule, owners or operators of facilities that contain titanium dioxide production processes (as defined below) must report emissions from titanium dioxide production and all other source categories located at the facility for which methods are defined in the rule. Owners or operators are required to collect emission data; calculate GHG emissions; and follow the specified procedures for quality assurance, missing data, recordkeeping, and reporting. How Is This Source Category Defined? The titanium dioxide production source category consists of any facility that uses the chloride process to produce titanium dioxide. What GHGs Must Be Reported? Each titanium dioxide production facility must report carbon dioxide (CO2) process emissions from each chloride process line. In addition, each facility must report GHG emissions for other source categories for which calculation methods are provided in the rule. For example, facilities must report CO2, nitrous oxide (N2O), and methane (CH4) emissions from each stationary combustion unit on site by following the requirements of 40 CFR part 98, subpart C (General Stationary Fuel Combustion Sources). Please refer to the relevant information sheet for a summary of the rule requirements for calculating and reporting emissions from any other source categories at the facility. How Must GHG Emissions Be Calculated? Reporters must calculate CO2 process emissions using one of two methods, as appropriate: • Installing and operating a continuous emission monitoring system (CEMS) according to the requirements specified in 40 CFR part 98, subpart C. • Calculating the process CO2 emissions for each process line using monthly measurements of the mass and carbon content of calcined petroleum coke.
    [Show full text]
  • Nitrogen Dioxide
    Common Name: NITROGEN DIOXIDE CAS Number: 10102-44-0 RTK Substance number: 1376 DOT Number: UN 1067 Date: May 1989 Revision: April 2000 ----------------------------------------------------------------------- ----------------------------------------------------------------------- HAZARD SUMMARY * Nitrogen Dioxide can affect you when breathed in. * If you think you are experiencing any work-related health * Nitrogen Dioxide may cause mutations. Handle with problems, see a doctor trained to recognize occupational extreme caution. diseases. Take this Fact Sheet with you. * Contact can irritate and burn the skin and eyes with * Exposure to hazardous substances should be routinely possible eye damage. evaluated. This may include collecting personal and area * Breathing Nitrogen Dioxide can irritate the nose and air samples. You can obtain copies of sampling results throat. from your employer. You have a legal right to this * Breathing Nitrogen Dioxide can irritate the lungs causing information under OSHA 1910.1020. coughing and/or shortness of breath. Higher exposures can cause a build-up of fluid in the lungs (pulmonary edema), a medical emergency, with severe shortness of WORKPLACE EXPOSURE LIMITS breath. OSHA: The legal airborne permissible exposure limit * High levels can interfere with the ability of the blood to (PEL) is 5 ppm, not to be exceeded at any time. carry Oxygen causing headache, fatigue, dizziness, and a blue color to the skin and lips (methemoglobinemia). NIOSH: The recommended airborne exposure limit is Higher levels can cause trouble breathing, collapse and 1 ppm, which should not be exceeded at any even death. time. * Repeated exposure to high levels may lead to permanent lung damage. ACGIH: The recommended airborne exposure limit is 3 ppm averaged over an 8-hour workshift and IDENTIFICATION 5 ppm as a STEL (short term exposure limit).
    [Show full text]
  • Recent Advances in Tio2-Based Photocatalysts for Reduction of CO2 to Fuels
    nanomaterials Review Recent Advances in TiO2-Based Photocatalysts for Reduction of CO2 to Fuels 1,2, 3, 4 5 Thang Phan Nguyen y, Dang Le Tri Nguyen y , Van-Huy Nguyen , Thu-Ha Le , Dai-Viet N. Vo 6 , Quang Thang Trinh 7 , Sa-Rang Bae 8, Sang Youn Chae 9,* , Soo Young Kim 8,* and Quyet Van Le 3,* 1 Laboratory of Advanced Materials Chemistry, Advanced Institute of Materials Science, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam; [email protected] 2 Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam 3 Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam; [email protected] 4 Key Laboratory of Advanced Materials for Energy and Environmental Applications, Lac Hong University, Bien Hoa 810000, Vietnam; [email protected] 5 Faculty of Materials Technology, Ho Chi Minh City University of Technology (HCMUT), Vietnam National University–Ho Chi Minh City (VNU–HCM), 268 Ly Thuong Kiet, District 10, Ho Chi Minh City 700000, Vietnam; [email protected] 6 Center of Excellence for Green Energy and Environmental Nanomaterials (CE@GrEEN), Nguyen Tat Thanh University, 300A Nguyen Tat Thanh, District 4, Ho Chi Minh City 755414, Vietnam; [email protected] 7 Cambridge Centre for Advanced Research and Education in Singapore (CARES), Campus for Research Excellence and Technological Enterprise (CREATE), 1 Create Way, Singapore 138602, Singapore; [email protected] 8 Department of Materials Science and Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea; [email protected] 9 Department of Materials Science, Institute for Surface Science and Corrosion, University of Erlangen-Nuremberg, Martensstrasse 7, 91058 Erlangen, Germany * Correspondence: [email protected] (S.Y.C.); [email protected] (S.Y.K.); [email protected] (Q.V.L.); Tel.: +42-01520-2145321 (S.Y.C.); +82-109-3650-910 (S.Y.K.); +84-344-176-848 (Q.V.L.) These authors contributed equally to this work.
    [Show full text]